Syntegon has introduced the AIM9 inspection platform, a high-speed system that combines visual inspection and leak detection for pharmaceutical vial applications. Announced on February 18, 2026, in Stuttgart, Germany, the platform is designed to process up to 600 vials per minute and handle container sizes ranging from 2 ml to 250 ml.
The automated system is intended for pharmaceutical manufacturers and contract manufacturing organisations (CMOs) operating in high-performance production environments. “Efficiency is key in the fast-paced pharmaceutical industry,” said Bernd Barkey, President of Syntegon Japan and Global Head of Inspection. “The new AIM9 enables our customers to boost productivity and meet ambitious delivery targets.”
The platform integrates Container Closure Integrity Testing (CCIT) directly into the inspection process. It supports headspace gas analysis, high-voltage leak detection, or a combination of both, without requiring additional standalone equipment. In addition, AIM9 incorporates a range of visual inspection technologies for detecting particles and cosmetic defects.
These include Syntegon’s patented SD technology, as well as area and line-scan cameras. Optional features such as deep learning integration and a bubble masking tool are available to help differentiate harmless bubbles from critical defects. The system is designed to achieve high detection capability while reducing false reject rates.
Syntegon states that the AIM9 is based on established transport and handling technology used by customers globally. The platform is available in several variants built on a standardized design. “Backed by many decades of experience, we can offer our customers exactly what they need to achieve the required performance, efficiency, and flexibility in their inspection process,” Barkey added.